A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy

International Journal of Rheumatic Diseases

Volumn 12, Issue 4, 2009, Pages 366-369

  Lui, Nai Lee ^a   Thumboo, Julian ^a,b,c   Fong, Kok Yong ^a,b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Cutaneous vasculitides; Hyperbaric oxygenation; Rituximab; Vasculitis

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYGEN; PREDNISOLONE; RITUXIMAB; RNA ANTIBODY;

ADULT; ALOPECIA; ANAMNESIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROTIC SYNDROME; PHOTOSENSITIVITY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; VASCULITIC ULCER; VASCULITIS; VASCULITIS ULCER;

ADULT; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERBARIC OXYGENATION; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; LEG ULCER; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHOTREXATE; PREDNISOLONE; TREATMENT OUTCOME; VASCULITIS;

EID: 71149083512     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01438.x     Document Type: Article

References (16)

1. Kumar N, Choudhary N, Agarwal G, Rizvi Y, Kaul B, Ahlawat R. Extensive medium-vessel vasculitis with SLE: an unusual association. J Clin Rheumatol 2007, 13:140-2.
2. Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997, 6:235-42.
3. Ramos-Casals M, Nardi N, Lagrutta M. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006, 85:95-104.
4. Weyand CM, Goronzy JJ. Pathogenesis of medium- and large-vessel vasculitis. Z Rheumatol 2009, 68:100-7. German
5. Carvalho D, Savage CO, Isenberg D, Pearson JD. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulating the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999, 42:631-40.
6. Chung SA, Seo P. Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol 2009, 21:3-9.
7. Protheroe A, Edwards JC, Simmons A, Maclennan K, Selby P. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford) 1999, 38:1150-2.
8. Flossmann O, Jones RB, Jayne DR, Luqmani RA. Should rituximab be used to treat anti-neutrophil cytoplasmic antibody associated vasculitis?. Ann Rheum Dis 2006, 65:841-4.
9. Walsh M, Jayne D. Targeting the B cell in vasculitis. Pediatr Nephrol 2009, 24:1267-75.
10. Mitchison NA. T-cell-B-cell cooperation. Nat Rev Immunol 2004, 4:308-12.
11. Kallenbach M, Duan H, Ring T. Rituximab induced remission in a patient with Wegener's granulomatosis. Nephron Clin Pract 2005, 99:c92-6.
12. Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 2006, 45:1432-6.
13. Tamura N, Matsudaira R, Hirashima M. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab. Intern Med 2007, 46:409-14.
14. Smith KG, Jones RB, Burns SM, Jayne DR. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum 2006, 54:2970-82.
15. Gansauge S, Breitbart A, Rinaldi N, Schwarz-Eywill M. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). Ann Rheum Dis 1997, 56:382-5.
16. Efrati S, Bergan J, Fishlev G, Tishler M, Golik A, Gall N. Hyperbaric oxygen therapy for non-healing vasculitic ulcers. Clin Exp Dermatol 2007, 32:12-7.